Check out this infographic summary.
Thanks to contributors Dr. Rebecca Hammon and Dr. Ashok Jethwa
Advancing Education, Research, and Quality of Care for the Head and Neck oncology patient.
Published on by AHNS Webmaster
Check out this infographic summary.
Thanks to contributors Dr. Rebecca Hammon and Dr. Ashok Jethwa
Published on by Mark Wax
blog article from the ASN Cutaneous Cancer Section
When large metastases are present in the parotid bed, surgical excision is the preferred modality of treatment. Depending on the extent of the disease, either a classic superficial parotidectomy or a near total parotidectomy with excision of the deep lobe may be required for complete clearance of the nodal tissue. A comprehensive or limited neck dissection may also be concurrently performed.
This resection of the parotid gland can lead to significant concavity deformities (Figure 1).
Historically, the volume defect had not been reconstructed. Over time, the soft tissue defect may have less abrupt edges and soften, but the concavity will always be present. The concavity imparts no functional deficits but may result in cosmetic dissatisfaction. In the setting of malignancy, the cosmetic deformity is often considered by most surgeons to be a minor issue in the post-operative period as concern for facial nerve function predominates.
Patients, however, can have differing opinions on the cosmetic outcome of an extensive parotidectomy with concavity deformity1. Ciuman et al demonstrated that parotidectomy for benign disease did not impact overall quality of life, but cosmetic discontent with the facial contour deformity was quite high with 70% reporting a change in appearance.2 Greater than half reported noticeable depression as a result of the cosmetic deformity. Casual observers were also able to notice the contour defect. A review of 274 patients by Bianchi et al discovered that the most essential factor impacting aesthetic outcome was the amount of parotid tissue removal.3 However, the full impact of the contour defect on patient’s quality of life has not been fully elucidated due to the lack of symptom specific questions on quality-of-life instruments1.
Minimal parotidectomy with neck dissection may yield smaller volume defects and spare involvement of the overlying cutaneous tissue. Surgical reconstruction of the facial skin in this situation is not required and the volume defect may be addressed with a range of reconstructive options. The reconstructive paradigm to address soft tissue defects ranges from sternocleidomastoid (SCM) muscle flaps, acellular dermal implants, superficial musculoaponeurotic system (SMAS) plication, fat graft, and free tissue transfer.4,5 Both the SMAS plication and SCM muscle flap have been shown to be equivalent to soft tissue fillers and result in improved patient satisfaction with their final appearance4. Acellular dermal implants like Alloderm and fat grafting are ideal for smaller volume parotid defects (Figure 2).
Reconstructive options are primarily volume-driven and often imparts no alterations in overall functional status. It is our preference to consider reconstruction in the majority of parotidectomy defects. Small contour defects are easily reconstructed by the ablative team at the time of the initial surgery. Larger defects are approached and a 2-team fashion with involvement of our facial plastics colleagues. When malignancy surveillance is required, it is often done with radiologic imaging so the reconstructive modality used does not impact surveillance or outcome. All reconstructive tissues will atrophy or shrink over time. if adjuvant radiation is expected; fat grafting may atrophy significantly. In our experience it is rare to have patients unhappy with too much bulk in the reconstruction. As with most fat grafting and other parts of the head and neck up to 50% greater volume should be utilized depending on what the next course of treatment is. When there is cutaneous involvement and the defect is not extensive, cervicofacial advancement flaps are ideal for functional and cosmetic reconstruction.
Soft tissue defects greater than 70 cm3 are more common in the setting of advanced metastatic skin cancer to the parotid bed since extensive parotidectomy with concurrent neck dissection is usually necessary, and local constructive modalities are not adequate in these situations.6 There is an increased risk of facial skin involvement with aggressive disease, resulting in another layer of complexity in the reconstruction. Scenarios where local tissue may not be ideal include the large size of the defect, previous rotational flaps disrupting the facial skin or soft tissue blood supply, prior radiation history, heavy smoker, or poor prognostic indicators for wound healing. When defects are of a more significant nature or the wound bed is a more hostile environment, then regional or free tissue transfer should be considered (Figure 3 a,b).5
Utilization of free tissue transfer for parotid skin defects are relatively rare. When necessary, the ideal flap would provide not only coverage of the skin defect, but also would reconstruct the soft tissue defect from parotidectomy and neck dissection. Radial forearm free flaps and anterolateral thigh flaps are most commonly used. The lateral arm flap has recently been proposed in the literature as another alternative option. The ultimate decision depends on the volume of tissue required and patient body habitus (Figure 4a,b,c).4
Patients seem to anecdotally report favorable outcomes after free tissue transfer. Cannady et al described a series of 18 patients with free tissue transfer for soft tissue volume reconstruction of total parotidectomy defects with acceptably cosmetic outcomes reported by patients.5 The benefits of free tissue transfer include healthy vascularized tissue in the wound bed, especially if adjunct radiation therapy is to be pursued post-operatively, adequate skin paddle for facial skin defects with no local tissue available for rotation, and adipose or muscular tissue to address the soft tissue volume loss. Unlike a fat graft, vascularized adipose tissue is less likely to atrophy to the same extent.
In terms of free tissue transfer, radial forearm flap, anterolateral thigh flap, and lateral arm flap are acceptable options when both a skin and soft tissue defect needs to be addressed. When there is no facial skin defect, an adipose fascial free flap from the thigh that results in minimal donor site morbidity may be a more suitable reconstructive modality. Described by Fritz et al, this flap can be harvested as a 2-team approach with a straightforward inset and vascular anastomosis adding an hour or two to the overall length of the surgery.7 Even though vascularized adipose tissue does not shrink like fat grafts, there is a possibility that these grafts will also atrophy to a considerable extent like other free tissue transfers.8 Long-term data is lacking, but there may be a role in overcorrection of the soft tissue volume loss at the time of reconstruction in anticipation of volume loss, especially in the setting of post-operative radiation therapy.
Reconstruction of the parotid bed volume loss may not be like other typical head and neck reconstructions since there is no functional role. Anecdotal evidence from patients report poor cosmetic outcomes and overall dissatisfaction with contour deformities with this defect. There is very little quantitative evidence in the literature regarding its impact on the overall quality of life, but there may still be a role for parotid bed reconstruction to obtain good cosmetic outcomes. Reconstructive options are relatively straightforward and should be considered during pre-operative evaluation. Patient morbidity from reconstruction is relatively minor. The benefits are potentially major.
Mark K Wax MD FACS FRCS(C) 1
Professor Otolaryngology-HNS
Professor Maxillo Facial Surgery
Program Director
Sara Yang MD1
Fellow Microvascular and Reconstructive Surgery
Oregon Health Sciences University
References
Published on by AHNS Webmaster
AHNS members,
Please take a moment to distribute information on the upcoming US vs. HPV Prevention Week to your patients and colleagues. This joint initiative between the Global Initiative Against HPV and Cervical Cancer (GIAHC), American Medical Women’s Association (AMWA) and Indiana University National Center of Excellence in Women’s Health will take place next week from January 23- January 27, 2023. This FREE event will include a session on Thursday, January 26th from 12-1PM EST entitled “HPV Oropharynx Cancer: What You Need to Know in 2023” and will include presentations from several AHNS members.
Register here to register for the FREE live or recorded webinars. These webinars are designed to reach a broad audience, including oncologists treating HPV-related cancers, primary care physicians, allied health professionals, and patients. Please join us in fighting against HPV-related cancers.
The full agenda can be accessed here and additional background information can be accessed here. The agenda for Thursday’s session is included below.
Sincerely,
AHNS Cancer Prevention Service
January 26th, 12-1PM EST
HPV Oropharynx Cancer: What You Need to Know in 2023
Moderator:
Cecelia E. Schmalbach, MD, MSc, FACS
David Myers, MD Professor and Chair
Department of Otolaryngology-Head & Neck Surgery
Director, Temple Head and Neck Institute
Lewis Katz School of Medicine at Temple University
HPV Head & Neck Cancer: 2023 Update
Gina D. Jefferson, MD, MS, FACS
Professor of Otolaryngology-HNS
Vice Chair of Education; Division Chief, Head & Neck Surgery
The University of Mississippi Medical Center
HPV Induced Oropharyngeal Cancer: What to Look For & How to Treat
Anthony Morlandt, MD, DDS, FACS
Professor & Chief, Oral Oncology
Director, Head & Neck Oncology Fellowship
Dept. of OMS, Univ. of Alabama at Birmingham
The Patient’s Journey
Alice C. Lin, MD, FACS
Head & Neck Surgery, Dept. of Otolaryngology
Kaiser Permanente
Los Angeles, CA
Jacqueline Sol
Patient
Live Question/Answer Session
Published on by AHNS Webmaster
The American Head and Neck Society’s Cancer Prevention Service is pleased to offer the 2023 Cancer Prevention Community Service Awards. These awards support projects or community activities related to oral head and neck cancer awareness and prevention. Each award, in the amount of $1,000.00, will be given to an individual, department, organization, or institution in support of a patient or community-oriented project held in conjunction with Oral Head & Neck Cancer Awareness Week (OHANCAW), the annual awareness & prevention event presented by our colleagues at the Head & Neck Cancer Alliance. The 2023 OHANCAW takes place April 16-22, 2023.
A total of five (5) awards are granted – four (4) AHNS Community Service Awards and an international award funded by the Head and Neck Cancer Alliance – the HNCA/AHNS International Outreach Cancer Prevention Award.
Applicants must submit a letter, not to exceed 2 typed pages, containing a detailed description of the project and including the following:
Applications are due Monday, February 20th at midnight Eastern Time. Recipients will be announced in mid March.
Please note that indirect support and salary are not supported as part of this award. Recipients of this award, upon completion of their project, will be requested to submit a brief report describing how the funding was spent, the results of the project and an overall evaluation.
Published on by AHNS Webmaster
Join us for the AHNS Endocrine Section Town Hall on Focused Practice Designation for Adult Complex Thyroid/Parathyroid Surgery”
Wednesday, February 8, 2023, at 7:00 PM Eastern Time (USA/Canada)
Brian B. Burkey, MD, MEd – AHNS President: Welcome and Overview
Brian Nussenbaum ABO to Executive Director: Board Objectives
Dave Steward and Lisa Orloff AAO FPD: AAO perspectives
Greg Randolph and Cherie Ann Nathan AHNS FPD:AHNS perspectives
Donald Weed The ATC: Fellows perspective
Moderators:
Brian Burkey, Mike Singer and Brendan Stack: Q and A from Audience
Objectives
One-hour session is free to all registrants!